Search

Your search keyword '"Yamamoto, Manabu"' showing total 658 results
Start Over Author "Yamamoto, Manabu" Publication Year Range Last 10 years
658 results on '"Yamamoto, Manabu"'

2. Importance of duodenal stump reinforcement to prevent stump leakage after gastrectomy: a large-scale multicenter retrospective study (KSCC DELICATE study)

Author

Sano, Akihiko, Imai, Yoshiro, Yamaguchi, Takahisa, Bamba, Takeo, Shinno, Naoki, Kawashima, Yoshiyuki, Tokunaga, Masanori, Enokida, Yasuaki, Tsukada, Tomoya, Hatakeyama, Satoru, Koga, Tadashi, Kuwabara, Shirou, Urakawa, Naoki, Arai, Junichi, Yamamoto, Manabu, Yasufuku, Itaru, Iwasaki, Hironori, Sakon, Masahiro, Honboh, Takuya, Kawaguchi, Yoshihiko, Kusumoto, Tetsuya, Shibao, Kazunori, Hiki, Naoki, Nakazawa, Nobuhiro, Sakai, Makoto, Sohda, Makoto, Shirabe, Ken, Oki, Eiji, Baba, Hideo, and Saeki, Hiroshi

Published
2024
Full Text
View/download PDF

4. Robotic versus open and laparoscopic pelvic exenterations for pelvic cancer: a multicenter propensity-matched analysis in Japan

Author

Yatabe, Yusuke, Hanaoka, Marie, Hanazawa, Ryoichi, Hirakawa, Akihiro, Mukai, Toshiki, Kimura, Kei, Yamanoi, Koji, Kono, Jin, Yokota, Mitsuru, Takahashi, Hiroki, Kobayashi, Akihiro, Kobayashi, Kenji, Ichikawa, Nobuki, Yasui, Masayoshi, Nakane, Keita, Yamamoto, Manabu, Takenaka, Atsushi, Nakamura, Yuya, Takemasa, Ichiro, Yabusaki, Norimitsu, Akamoto, Shintaro, Tatarano, Shuichi, Murata, Kohei, Manabe, Tatsuya, Fujimura, Tetsuya, Kawamura, Mikio, Egi, Hiroyuki, Yamaguchi, Shigeki, Terai, Yoshito, Inoue, Shigetaka, Ito, Akihiro, and Kinugasa, Yusuke

Published
2024
Full Text
View/download PDF

5. Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis

Author

Makinoya, Masahiro, Miyatani, Kozo, Matsumi, Yoshiaki, Sakano, Yu, Shimizu, Shota, Shishido, Yuji, Hanaki, Takehiko, Kihara, Kyoichi, Matsunaga, Tomoyuki, Yamamoto, Manabu, Tokuyasu, Naruo, Takano, Shuichi, Sakamoto, Teruhisa, Hasegawa, Toshimichi, Saito, Hiroaki, Nakayama, Yuji, Osaki, Mitsuhiko, Okada, Futoshi, and Fujiwara, Yoshiyuki

Published
2024
Full Text
View/download PDF

9. A low cumulative perioperative prognostic nutritional index predicts poor long-term outcomes in patients with gastric cancer: A single-center retrospective study in Japan

Author

Miyatani, Kozo, Sakano, Yu, Makinoya, Masahiro, Miyauchi, Wataru, Shimizu, Shota, Shishido, Yuji, Hanaki, Takehiko, Kihara, Kyoichi, Matsunaga, Tomoyuki, Yamamoto, Manabu, Tokuyasu, Naruo, Takano, Shuichi, Sakamoto, Teruhisa, Hasegawa, Toshimichi, Saito, Hiroaki, and Fujiwara, Yoshiyuki

Published
2023
Full Text
View/download PDF

10. The Genome-wide DNA methylation changes in gastrointestinal surgery patients with and without postoperative delirium: Evidence of immune process in its pathophysiology

Author

Nishizawa, Yoshitaka, Yamanashi, Takehiko, Nishiguchi, Tsuyoshi, Kajitani, Naofumi, Miura, Akihiko, Matsuo, Ryoichi, Tanio, Akimitsu, Yamamoto, Manabu, Sakamoto, Teruhisa, Fujiwara, Yoshiyuki, Thompson, Kaitlyn, Malicoat, Johnny, Yamanishi, Kyosuke, Seki, Tomoteru, Kanazawa, Tetsufumi, Iwata, Masaaki, and Shinozaki, Gen

Published
2024
Full Text
View/download PDF

11. Estimation of the physiologic ability and surgical stress scoring system as a useful predictor of postoperative recurrence in patients with stage II colorectal cancer: a multicenter study

Author

Tanio, Akimitsu, Saito, Hiroaki, Hara, Kazushi, Sugezawa, Ken, Uejima, Chihiro, Kihara, Kyoichi, Tatebe, Shigeru, Kurisu, Yasuro, Shibata, Shunsuke, Yamamoto, Toshio, Nishie, Hiroshi, Shiota, Setsujo, Naka, Takuji, Sugamura, Kenji, Katano, Kuniyuki, Yamamoto, Manabu, and Fujiwara, Yoshiyuki

Published
2023
Full Text
View/download PDF

12. EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment: A multicenter retrospective observational study

Author

Araki, Taisuke, Kanda, Shintaro, Obara, Miho, Agatsuma, Toshihiko, Kakizaki, Yumiko, Hama, Mineyuki, Yamamoto, Hiroshi, Takada, Munetake, Yamamoto, Manabu, Matsuo, Akemi, Kondo, Daichi, Komatsu, Masamichi, Sonehara, Kei, Tateishi, Kazunari, Hanaoka, Masayuki, and Koizumi, Tomonobu

Published
2024
Full Text
View/download PDF

16. Laparoscopic pelvic lymph node dissection in cadaver surgical training from the combined perspectives of urologists, gastroenterologists and gynecologists improves overall knowledge and technique: initial experience of multidisciplinary cadaver surgical training at a single institution in Japan

Author

Morizane, Shuichi, Honda, Masashi, Kihara, Kyoichi, Yamamoto, Manabu, Komatsu, Hiroaki, Sato, Shinya, Hikita, Katsuya, Tanishima, Shinji, Nakane, Hironobu, Kurosaki, Masamichi, Kaidoh, Toshiyuki, and Takenaka, Atsushi

Published
2022
Full Text
View/download PDF

19. Impact of Endoscopic Surgical Skill Qualification System‐certified surgeons as operators in laparoscopic rectal cancer surgery in Japan: A propensity score‐matched analysis (subanalysis of the EnSSURE study).

Author

Kojo, Ken, Yamanashi, Takahiro, Homma, Shigenori, Yamamoto, Manabu, Miura, Takuya, Ishii, Yoshiyuki, Ishibe, Atsushi, Ogawa, Hiroomi, Ichikawa, Nobuki, Iijima, Hiroaki, Inomata, Masafumi, Taketomi, Akinobu, and Naitoh, Takeshi

Subjects
RECTAL cancer, PROPENSITY score matching, LAPAROSCOPIC surgery, ONCOLOGIC surgery, RECTAL surgery, LYMPH nodes
Abstract

Background: In Japan, the Endoscopic Surgical Skill Qualification System (ESSQS) is used to evaluate surgical skills essential for laparoscopic surgery, but whether surgeons with this certification as operators improve the short‐term outcomes and prognosis after rectal cancer surgery is unclear. This cohort study was designed to compare the short‐term and long‐term outcomes of laparoscopic surgery for advanced rectal cancer performed by an ESSQS‐certified surgeon versus a surgeon without ESSQS certification. Methods: The outcomes of cStage II and III rectal cancer surgery cases performed at 56 Japanese hospitals between 2014 and 2016 were retrospectively reviewed. To examine the impact of ESSQS‐certified surgeons as surgeons, the outcomes of cases with only ESSQS‐certified surgeons as operators were compared with those without involvement of ESSQS‐certified surgeons. Results: A total of 3197 cases were enrolled, with 1015 in which surgery was performed by ESSQS‐certified surgeons, and 544 in which there was no involvement of ESSQS‐certified surgeons. After propensity score matching, the ESSQS group had significantly shorter operative time (p < 0.001), a lower conversion rate to open surgery (p < 0.001), and more dissected lymph nodes (p = 0.002). Conclusion: Laparoscopic rectal surgery performed by ESSQS‐certified surgeons was significantly associated with improved short‐term outcomes. This demonstrates the utility of the ESSQS certification system. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Circular stapling anastomosis with indocyanine green fluorescence imaging for cervical esophagogastric anastomosis after thoracoscopic esophagectomy: a propensity score-matched analysis

Author

Shishido, Yuji, Matsunaga, Tomoyuki, Makinoya, Masahiro, Miyauchi, Wataru, Shimizu, Shota, Miyatani, Kozo, Uejima, Chihiro, Morimoto, Masaki, Murakami, Yuki, Hanaki, Takehiko, Kihara, Kyoichi, Yamamoto, Manabu, Tokuyasu, Naruo, Takano, Shuichi, Sakamoto, Teruhisa, Saito, Hiroaki, Hasegawa, Toshimichi, and Fujiwara, Yoshiyuki

Published
2022
Full Text
View/download PDF

29. Prognostic Value of Integrated Assessment of Cardiac Magnetic Resonance-Derived Global Coronary Flow Reserve and Cardiopulmonary Exercise Testing-Derived Peak Oxygen Consumption in Patients With Acute Myocardial Infarction

Author

Sugiyama, Tomoyo, primary, Kanaji, Yoshihisa, additional, Hoshino, Masahiro, additional, Hada, Masahiro, additional, Hanyu, Yoshihiro, additional, Nagamine, Tatsuhiro, additional, Nogami, Kai, additional, Ueno, Hiroki, additional, Matsuda, Kazuki, additional, Sayama, Kodai, additional, Sakamoto, Tatsuya, additional, Usui, Eisuke, additional, Wakasa, Nobutaka, additional, Umino, Takashi, additional, Hamano, Ippei, additional, Yamamoto, Manabu, additional, Yonetsu, Taishi, additional, Sasano, Tetsuo, additional, and Kakuta, Tsunekazu, additional

Published
2024
Full Text
View/download PDF

30. Correlation between relative dose intensity of adjuvant S-1 chemotherapy and psoas muscle mass volume and survival after resection of pancreatic ductal adenocarcinoma: A retrospective study

Author

Sakamoto, Teruhisa, primary, Kishino, Mikiya, additional, Murakami, Yuki, additional, Miyatani, Kozo, additional, Hanaki, Takehiko, additional, Shishido, Yuji, additional, Kihara, Kyoichi, additional, Matsunaga, Tomoyuki, additional, Yamamoto, Manabu, additional, Tokuyasu, Naruo, additional, and Fujiwara, Yoshiyuki, additional

Published
2024
Full Text
View/download PDF

35. One-Year Outcome of Intravitreal Injection of Ranibizumab Biosimilar for Myopic Choroidal Neovascularization in Japanese Patients.

Author

Tomita, Mami, Yamamoto, Manabu, Hirayama, Kumiko, Kyo, Akika, Misawa, Norihiko, Kinari, Gen, Kohno, Takeya, and Honda, Shigeru

Subjects
*INTRAVITREAL injections, *JAPANESE people, *VISUAL acuity, *RANIBIZUMAB, *TREATMENT effectiveness
Abstract

Objectives: To evaluate the one-year outcomes of intravitreal ranibizumab biosimilar (RBZ-BS) injections for myopic choroidal neovascularization (mCNV) in Japanese patients. Methods: Twenty-one patients (mean age 69.0 years; 4 males, 17 females) with high myopia and mCNV were retrospectively reviewed. Twelve were treatment-naïve, and nine had previous anti-VEGF treatments. Efficacy measures included best-corrected visual acuity (BCVA) and central macular thickness (CMT). Results: The treatment-naïve group showed significant BCVA improvement from 0.55 ± 0.34 at baseline to 0.24 ± 0.28 at 12 months. The previously treated group had no significant BCVA changes. CMT significantly decreased in both groups: from 295.3 ± 105.2 µm to 207.3 ± 63.0 µm in the treatment-naïve group, and from 196.1 ± 62.0 µm to 147.2 ± 50.1 µm in the previously treated group. Dry macula rates were high: 83% at 3 months and 83% at 12 months in the treatment-naïve group, and 67% at 3 months and 89% at 12 months in the previously treated group. No adverse events were reported. Conclusions: These findings indicate that RBZ-BS is an effective and safe treatment for mCNV, particularly in treatment-naïve patients. The use of RBZ-BS offers a cost-effective alternative to original ranibizumab, reducing financial burdens while maintaining high therapeutic efficacy. Further studies with larger sample sizes and longer follow-up periods are needed to confirm these results and evaluate long-term outcomes and cost-effectiveness. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

36. Switching to Intravitreal Brolucizumab after Ranibizumab or Aflibercept Using Treat and Extend Regimen for Neovascular Age-Related Macular Degeneration in Japanese Patients: 1-Year Results and Factors Associated with Treatment Responsiveness.

Author

Hirayama, Kumiko, Yamamoto, Manabu, Honda, Shigeru, Kyo, Akika, Misawa, Norihiko, and Kohno, Takeya

Subjects
*MACULAR degeneration, *CHOROID, *JAPANESE people, *AFLIBERCEPT, *MULTIVARIATE analysis
Abstract

Objective: To purpose of this study was to retrospectively evaluate the 1-year outcomes and factors associated with the treatment responsiveness of switching to intravitreal brolucizumab (IVBR) for neovascular age-related macular degeneration (nAMD) in Japanese patients refractory to ranibizumab or aflibercept using a treat and extend (TAE) regimen. Methods: A total of 48 eyes of 47 nAMD patients were switched to IVBR, and 36 eyes of 35 patients (27 males and 8 females) underwent 1-year treatment after the switch. Results: The rate of dry macula was significantly higher 12 months after the switch to IVBR (p < 0.001), with a significant decrease in the mean central macular thickness (CMT) and the mean central choroidal thickness (CCT) (p < 0.01 and p < 0.01, respectively). The injection interval was significantly extended from 7.0 ± 1.7 weeks to 10.3 ± 2.5 weeks 12 months after the switch (p < 0.001). In the multivariate analysis, a smaller number of prior anti-VEGF injections (p = 0.025; odds ratio: 0.947; 95% confidence interval: 0.903–0.994) and a pre-switching CCT of less than 250 µm (p = 0.023; odds ratio: 0.099; 95% confidence interval: 0.013–0.731) were associated with the good response group. Conclusions: These results suggest that IVBR may suppress disease activity and prolong the injection interval by switching for AMD patients with an insufficient response to treatment with ranibizumab and aflibercept. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

39. High Pretreatment Mean Corpuscular Volume Can Predict Worse Prognosis in Patients With Esophageal Squamous Cell Carcinoma who Have Undergone Curative Esophagectomy: A Retrospective Multicenter Cohort Study

Author

Yoshida, Naoya, Sasaki, Ken, Kanetaka, Kengo, Kimura, Yasue, Shibata, Tomotaka, Ikenoue, Makoto, Nakashima, Yuichiro, Sadanaga, Noriaki, Eto, Kojiro, Tsuruda, Yusuke, Kobayashi, Shinichiro, Nakanoko, Tomonori, Suzuki, Kosuke, Takeno, Shinsuke, Yamamoto, Manabu, Morita, Masaru, Toh, Yasushi, and Baba, Hideo

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results